Anti-FCRLB/ FCRL2/ FCRLM2 functional antibody

Anti-FCRLB/ FCRL2/ FCRLM2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FCRLB/FCRLB products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1557-Ab-1/ GM-Tg-hg-SE1557-Ab-2Anti-Human FCRLB monoclonal antibodyHuman
GM-Tg-rg-SE1557-Ab-1/ GM-Tg-rg-SE1557-Ab-2Anti-Rat FCRLB monoclonal antibodyRat
GM-Tg-mg-SE1557-Ab-1/ GM-Tg-mg-SE1557-Ab-2Anti-Mouse FCRLB monoclonal antibodyMouse
GM-Tg-cynog-SE1557-Ab-1/ GM-Tg-cynog-SE1557-Ab-2Anti-Cynomolgus/ Rhesus macaque FCRLB monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1557-Ab-1/ GM-Tg-felg-SE1557-Ab-2Anti-Feline FCRLB monoclonal antibodyFeline
GM-Tg-cang-SE1557-Ab-1/ GM-Tg-cang-SE1557-Ab-2Anti-Canine FCRLB monoclonal antibodyCanine
GM-Tg-bovg-SE1557-Ab-1/ GM-Tg-bovg-SE1557-Ab-2Anti-Bovine FCRLB monoclonal antibodyBovine
GM-Tg-equg-SE1557-Ab-1/ GM-Tg-equg-SE1557-Ab-2Anti-Equine FCRLB monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1557-Ab-1/ GM-Tg-hg-SE1557-Ab-2; GM-Tg-rg-SE1557-Ab-1/ GM-Tg-rg-SE1557-Ab-2;
GM-Tg-mg-SE1557-Ab-1/ GM-Tg-mg-SE1557-Ab-2; GM-Tg-cynog-SE1557-Ab-1/ GM-Tg-cynog-SE1557-Ab-2;
GM-Tg-felg-SE1557-Ab-1/ GM-Tg-felg-SE1557-Ab-2; GM-Tg-cang-SE1557-Ab-1/ GM-Tg-cang-SE1557-Ab-2;
GM-Tg-bovg-SE1557-Ab-1/ GM-Tg-bovg-SE1557-Ab-2; GM-Tg-equg-SE1557-Ab-1/ GM-Tg-equg-SE1557-Ab-2
Products NameAnti-FCRLB monoclonal antibody
Formatmab
Target NameFCRLB
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCRLB benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1557-Ag-1Recombinant multi-species FCRLB/ FCRL2/ FCRLM2 protein


    Target information

    Target IDGM-SE1557
    Target NameFCRLB
    Gene ID127943,435653,498275,720028,609689,101087040,522702,100147023
    Gene Symbol and SynonymsFCRL2,FCRLB,FCRLM2,FCRLY,FcRY,FREB-2,FREB2,mFCRL2,RGD1563018
    Uniprot AccessionQ6BAA4
    Uniprot Entry NameFCRLB_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162746
    Target ClassificationN/A

    The target: FCRLB, gene name: FCRLB, also named as FCRL2, FCRLM2, FCRLY, FREB-2, FREB2, FcRY. FCRL2 belongs to the Fc receptor family. Fc receptors are involved in phagocytosis, antibody-dependent cell cytotoxicity, immediate hypersensitivity, and transcytosis of immunoglobulins via their ability to bind immunoglobulin (Ig) constant regions (Chikaev et al., 2005 [PubMed 15676285]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.